PubRank

D J Clark

Author PubWeight™ 87.14‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Regulation of deoxyribonucleic acid replication and cell division in Escherichia coli B-r. J Bacteriol 1968 6.17
2 The regulation of DNA replication and cell division in E. coli B-r. Cold Spring Harb Symp Quant Biol 1968 5.09
3 Selective broth medium for isolation of group B streptococci. Appl Microbiol 1973 4.42
4 Regulation of Cell Division in Escherichia coli: Characterization of Temperature-Sensitive Division Mutants. J Bacteriol 1970 4.30
5 Ampicillin prevents intrapartum transmission of group B streptococcus. JAMA 1979 3.00
6 Histone contributions to the structure of DNA in the nucleosome. Proc Natl Acad Sci U S A 1991 2.58
7 A histone octamer can step around a transcribing polymerase without leaving the template. Cell 1994 2.48
8 A 12 year review of the antibiotic management of Hemophilus influenzae meningitis. Comparison of ampicillin and conventional therapy including chloramphenicol. J Pediatr 1972 2.48
9 Laboratory and pharmacologic studies of BL-P-1322 (cephapirin sodium) in children. Curr Ther Res Clin Exp 1971 2.17
10 Polarized gamma-ray emission from the crab. Science 2008 2.05
11 Overcoming a nucleosomal barrier to transcription. Cell 1995 1.81
12 Nucleoside triphosphate pools in synchronous cultures of Escherichia coli. J Bacteriol 1971 1.68
13 Cell division of Escherichia coli BUG-6: effect of varying the length of growth at the nonpermissive temperature. J Bacteriol 1972 1.65
14 Salt-dependent co-operative interaction of histone H1 with linear DNA. J Mol Biol 1986 1.56
15 Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children. Thorax 1997 1.53
16 Influence of several antibiotics, singly and in combination, on the growth of Listeria monocytogenes. J Pediatr 1972 1.50
17 Effects of airway calibre on lung delivery of nebulised salbutamol. Thorax 1997 1.39
18 Chromatin assembly on replicating DNA in vitro. Nucleic Acids Res 1990 1.33
19 Sigma elements are position-specific for many different yeast tRNA genes. Nucleic Acids Res 1988 1.32
20 The natural history of group B streptococcal colonization in the pregnant woman and her offspring. I. Colonization studies. Am J Obstet Gynecol 1980 1.24
21 Cell division of Escherichia coli BUG-6: effect of varying the temperature used as the nonpermissive growth condition. J Bacteriol 1972 1.23
22 Two related genes encoding extremely hydrophobic proteins suppress a lethal mutation in the yeast mitochondrial processing enhancing protein. J Biol Chem 1992 1.22
23 Failure of penicillin to eradicate group B streptococcal colonization in the pregnant woman. A couple study. Am J Obstet Gynecol 1979 1.20
24 Effects of ionizing radiation on synchronous cultures of Escherichia coli B-r. J Bacteriol 1968 1.15
25 Pharmacokinetics and extrapulmonary beta 2 adrenoceptor activity of nebulised racemic salbutamol and its R and S isomers in healthy volunteers. Thorax 1997 1.13
26 Endocrine deficit after fractionated total body irradiation. Arch Dis Child 1992 1.12
27 Remodeling of yeast CUP1 chromatin involves activator-dependent repositioning of nucleosomes over the entire gene and flanking sequences. Mol Cell Biol 2001 1.11
28 A ten-year assessment of methicillin-associated side effects. Pediatrics 1976 1.08
29 Cell growth and division in Escherichia coli: a common genetic control involved in cell division and minicell formation. J Bacteriol 1973 1.08
30 DNA sequence plays a major role in determining nucleosome positions in yeast CUP1 chromatin. J Biol Chem 2001 1.07
31 In vitro susceptibility of Corynebacterium diphtheriae to thirteen antibiotics. Appl Microbiol 1971 1.04
32 An initiation element in the yeast CUP1 promoter is recognized by RNA polymerase II in the absence of TATA box-binding protein if the DNA is negatively supercoiled. Proc Natl Acad Sci U S A 2000 0.99
33 Lung delivery of salbutamol by dry powder inhaler (Turbuhaler) and small volume antistatic metal spacer (Airomir CFC-free MDI plus NebuChamber). Eur Respir J 1997 0.97
34 Lung delivery of non-CFC salbutamol via small volume metal spacer and large volume plastic spacer devices compared with an open vent jet nebulizer. Br J Clin Pharmacol 1998 0.96
35 Effect of human renal cationic transporter inhibition on the pharmacokinetics of varenicline, a new therapy for smoking cessation: an in vitro-in vivo study. Clin Pharmacol Ther 2007 0.92
36 Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype. J Virol 1997 0.90
37 Adrenocortical activity with repeated administration of one-daily inhaled fluticasone propionate and budesonide in asthmatic adults. Eur J Clin Pharmacol 1998 0.90
38 Role of C-terminal domain phosphorylation in RNA polymerase II transcription through the nucleosome. Biopolymers 2003 0.85
39 Lung delivery of salbutamol given by breath activated pressurized aerosol and dry powder inhaler devices. Pulm Pharmacol Ther 1997 0.85
40 Induction of a calcium/calmodulin-dependent phosphodiesterase during phytohemagglutinin-stimulated lymphocyte mitogenesis. J Biol Chem 1990 0.85
41 Early lung absorption profile of non-CFC salbutamol via small and large volume plastic spacer devices. Br J Clin Pharmacol 1998 0.85
42 Direct delayed human adenoviral BMP-2 or BMP-6 gene therapy for bone and cartilage regeneration in a pony osteochondral model. Osteoarthritis Cartilage 2011 0.85
43 Trends in door-to-balloon time and outcomes following primary percutaneous coronary intervention for ST-elevation myocardial infarction: an Australian perspective. Intern Med J 2014 0.84
44 The costs of treating febrile neutropenia in patients with malignant blood disorders. Pharmacoeconomics 1994 0.84
45 Incidence of kanamycin resistance among Escherichia coli isolates from neonates. J Pediatr 1974 0.83
46 Preparation of nucleosomal templates for transcription in vitro. Methods Enzymol 1996 0.82
47 Clinical outcomes of drug-eluting stent use in patients with ST elevation myocardial infarction. Int J Cardiol 2009 0.81
48 Comparative lung delivery of salbutamol given via Turbuhaler and Diskus dry powder inhaler devices. Eur J Clin Pharmacol 1997 0.81
49 Advances in percutaneous treatment for adult valvular heart disease. Intern Med J 2009 0.81
50 The detection of diverse aminoglycoside phosphotransferases within natural populations of actinomycetes. J Ind Microbiol Biotechnol 2002 0.80
51 Characterization of novel benzodiazepine ligands in Spodotera frugiperda (Sf-9) insect cells. Neurosci Lett 2001 0.80
52 Bioavailability of the oral selective phosphodiesterase 4 inhibitor cilomilast. Pharmacotherapy 2001 0.79
53 In vitro studies of 100 strains of meningococci: clinical implications. South Med J 1971 0.79
54 An overview of the pharmacokinetics of cilomilast (Ariflo), a new, orally active phosphodiesterase 4 inhibitor, in healthy young and elderly volunteers. J Clin Pharmacol 2001 0.79
55 The foundation and launch of the Melbourne Interventional Group: a collaborative interventional cardiology project. Heart Lung Circ 2005 0.78
56 Isolation of minichromosomes from yeast cells. Methods Enzymol 1999 0.78
57 Cilomilast: pharmacokinetic and pharmacodynamic interactions with digoxin. Clin Ther 2001 0.77
58 Warfarin pharmacodynamics unaffected by cilomilast. Ann Pharmacother 2001 0.77
59 Neutron-detected tomography of impurity-seeded superfluid helium. Phys Rev Lett 2004 0.77
60 Maternal haemolysis, elevated liver enzymes and low platelets syndrome: perinatal and neurodevelopmental neonatal outcomes for infants weighing less than 1250 g. J Paediatr Child Health 2004 0.76
61 Hemoglobin Chesterfield (beta 28 Leu----Arg) produces the phenotype of inclusion body beta thalassemia. Blood 1991 0.76
62 Comparison of Mueller-Hinton agar and oxoid sensitivity test medium in antibiotic susceptibility testing of Escherichia coli. Antimicrob Agents Chemother 1972 0.75
63 Familial antithrombin III deficiency and Mycoplasma pneumoniae pneumonia. J Clin Pathol 1991 0.75
64 Highly efficient infrared optical nonlinearity of a wide-bandgap chalcogenide Li(2)CdGeS(4). Opt Lett 2014 0.75
65 Antibiotic susceptibility patterns of enteropathogenic Escherichia coli isolates. South Med J 1974 0.75
66 K4GeP4Se12: a case for phase-change nonlinear optical chalcogenide. Opt Lett 2013 0.75
67 Metabolic effects of carnitine and carnitine analogs. Adv Exp Med Biol 1990 0.75
68 The ability of protan color defectives to perform color-dependent air traffic control tasks. Am J Optom Physiol Opt 1986 0.75
69 150 MeV proton medical cyclotron design study. Experientia Suppl 1975 0.75
70 Multidisciplinary approach to carotid stenting. Intern Med J 2010 0.75
71 Adrenal suppression with high doses of inhaled fluticasone propionate and triamcinolone acetonide in healthy volunteers. Eur J Clin Pharmacol 1997 0.75
72 Compound sodium lactate (Hartmann's) solution. Caution: risk of clotting. Anaesthesia 1986 0.75
73 Lack of a pharmacokinetic interaction between a new smoking cessation therapy, varenicline, and digoxin in adult smokers. Eur J Clin Pharmacol 2008 0.75
74 Primary care groups: nurses on the board. Nurs Stand 2000 0.75
75 Novel monochromatic optical density meter. J Biomed Eng 1993 0.75
76 Restitution of normal marrow morphology and karyotype in acute refractory acute promyelocytic leukaemia with all-trans retinoic acid. Br J Haematol 1991 0.75
77 How nurses can participate in the development of an ICNP. Int Nurs Rev 1997 0.75
78 Ability of deutan color defectives to perform simulated air traffic control tasks. Am J Optom Physiol Opt 1987 0.75
79 First measurement of the neutron beta asymmetry with ultracold neutrons. Phys Rev Lett 2009 0.75